metricas
covid
Buscar en
Revista de Psiquiatría y Salud Mental (English Edition)
Toda la web
Inicio Revista de Psiquiatría y Salud Mental (English Edition) Effects of the administration of (RS)-3,4-DCPG, a mixed AMPA receptor antagonist...
Journal Information
Vol. 2. Issue 3.
Pages 133-137 (January 2009)
Share
Share
Download PDF
More article options
Vol. 2. Issue 3.
Pages 133-137 (January 2009)
Full text access
Effects of the administration of (RS)-3,4-DCPG, a mixed AMPA receptor antagonist/mGluR8 receptor agonist, on aggressive behaviour in mice
Efectos de la administración de (RS)-3,4-DCPG, un antagonista mixto de los receptores AMPA y agonista de los receptores mGlu8, en la conducta agresiva de los ratones
Visits
1161
José Francisco Navarro
Corresponding author
navahuma@uma.es

Corresponding author.
, Vanessa de Castro, Mercedes Martín-López
Department of Psychobiology, Faculty of Psychology, University of Málaga, Málaga, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract
Introduction

Ionotropic and metabotropic (mGlu) receptors of glutamate have been suggested to be involved in the modulation of aggression. Thus, recent studies found reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice. Likewise, mGlu1 and 5 receptors have also been implicated in aggression regulation. (RS)-3,4-DCPG is a mixed antagonist of AMPA receptors and an agonist of mGluR8. The AMPA antagonist activity of this compound is determined by its R isomer while the S isomer is responsible for its mGluR8 agonistic properties.

Methods

We analyzed the effects of (RS)-3,4-DCPG (5, 10 and 20mg/kg, ip) on agonistic encounters between male mice. Individually housed mice were exposed to anosmic opponents 30min after drug administration. Ten min of dyadic interactions were staged between a singly housed and an anosmic mouse in a neutral area. The encounters were videotaped and the accumulated time allocated by subjects to 10 broad behavioral categories was estimated using an ethologically based analysis.

Results and conclusions

The results indicated that (RS)-3,4-DCPG produced no significant behavioral changes, suggesting that antagonism of AMPA receptors by the R isomer and stimulation of mGluR8 by the S isomer do not act synergistically on aggression in the racemic form of 3,4-DCPG.

Keywords:
Aggression
Glutamate
mGlu8 receptor
AMPA receptor
Agonistic behavior
Resumen
Introducción

Los receptores ionotrópicos y metabotrópicos (mGlu) de glutamato han sido implicados en la modulación de la agresión. Así, estudios recientes han encontrado una reducción de la agresión en ratones que carecen de la subunidad GluR-A de los receptores AMPA. Asimismo, los receptores mGlu1 y mGlu5 también se han involucrado en la regulación de la agresión. (RS)-3,4-DCPG es un antagonista mixto de receptores AMPA y agonista de receptores mGlu8. Su actividad antagonista AMPA está determinada por su isómero R, mientras que el isómero S es causal de sus propiedades agonistas mGlu8.

Métodos

En este estudio, se analiza el efecto de la administración de (RS)-3,4-DCPG (5, 10 y 20mg/kg, intraperitoneal) en los encuentros agonistas entre ratones machos; 30min después de la administración del fármaco se llevaron a cabo interacciones agonistas de 10min de duración entre un animal aislado y un oponente anósmico en un área neutral. Dichos encuentros se grabaron en vídeo para su análisis etológico mediante un programa de ordenador y se estimó el tiempo pasado por los ratones en cada una de diez categorías conductuales.

Resultados y conclusiones

Los resultados indicaron que el (RS)-3,4-DCPG no produjo cambios conductuales significativos, esto apunta a que el antagonismo de los receptores AMPA por el isómero R y la estimulación de los receptores mGlu8 por el isómero S no parecen actuar sinérgicamente sobre la agresión en la forma racémica del 3,4-DCPG.

Palabras clave:
Agresión
Glutamato
Receptores mGlu8
Receptores AMPA
Conducta agonista
Full text is only aviable in PDF
References
[1.]
R. Luján-Miras.
Receptores metabotrópicos del glutamato: nuevas dianas moleculares en la terapia de enfermedades neurológicas y psiquiátricas.
Rev Neurol, 40 (2005), pp. 43-53
[2.]
J.N.C. Kew, J.A. Kemp.
Ionotropic and metabotropic glutamate receptor: structure and pharmacology.
Psychopharmacology, 179 (2003), pp. 4-29
[3.]
F. Ferraguti, R. Shigemoto.
Metabotropic glutamate receptors.
Cell Tissue Res, 326 (2006), pp. 483-504
[4.]
R.E. Mustly, P.F. Consroe.
Phencyclidine produces aggressive behaviour in rapid eye movement sleep-deprived rats.
Life Sci, 30 (1982), pp. 1733-1738
[5.]
K. McAllister.
Ethological analysis of the effects of MK-801 upon aggressive male mice: similarity to chlordiazepoxide.
Pharmacol Biochem Behav, 37 (1990), pp. 101-106
[6.]
K.A. Miczek, M. Hanney.
Psychomotor stimulant effects of Damphetamine. MDMA and PCP-aggressive and schedule-controlled behaviour in mice.
Psychopharmacology, 115 (1994), pp. 358-365
[7.]
I.V. Belozertseva, A.Y. Bespalov.
Effects of NMDA receptor channel blockade on aggression in isolated male mice.
Aggressive Behav, 25 (1999), pp. 381-396
[8.]
O.Y. Vekoviskeva, T. Aitta-aho, O. Echenko, A. Kankaanpaa, T. Sépala, A. Honkanen, et al.
Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice.
Genes Brain Behav, 3 (2004), pp. 253-265
[9.]
O.Y. Vekoviskeva, T. Aitta-aho, E. Verbitskaya, K. Sandnabba, E.R. Korpi.
AMPA-type glutamate receptor antagonists on intermale social behaviour in two mouse lines bidirectionally selected for offensive aggression.
Pharmacol Biochem Behav, 87 (2007), pp. 241-247
[10.]
J.F. Navarro, E. Burón, M. Martín-López.
Antiaggressive effects of topiramate in agonistic encounters between male mice.
Methods Find Exp Clin Pharmacol, 29 (2007), pp. 195-198
[11.]
L.A. Lumley, L.C. Robinson, B.S. Slusher, K. Wozniak, M. Dawood, J.L. Meyerhoff.
Reduced isolation-induced aggressiveness in mice following NAALADase inhibition.
Psychopharmacology, 171 (2004), pp. 375-381
[12.]
J.F. Navarro, D. Postigo, M. Martín, E. Burón.
Antiaggressive effects of MPEP, a selective antagonist of mGlu5 receptors, in agonistic interactions between mice.
Eur J Pharmacol, 551 (2006), pp. 67-70
[13.]
P. Huertas, M. Martín-López, E. Burón, J.F. Navarro.
Efectos de la administración de (RS)-2-cloro-5-hidroxifenilglicina sobre la conducta agonística en ratones.
Psiq Biol, 14 (2007), pp. 199-203
[14.]
J.F. Navarro, V. De Castro, M. Martín-López.
JNJ16259685, a selective mGlu1 receptor antagonist, suppresses isolationinduced aggression in male mice.
Eur J Pharmacol, 586 (2008), pp. 217-220
[15.]
J.F. Navarro, M.J. Luque, M. Martín-López.
Effects of LY379268, a selective agonist of mGlu2/3 receptors, on isolation-induced aggression in male mice.
The Open Pharmacol J, 3 (2009), pp. 17-20
[16.]
J.F. Navarro, V. De Castro, M. Martín-López.
Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between male mice.
Psicothema, 21 (2009), pp. 475-479
[17.]
K. Owssowska, M. Pietraszek, J. Wards, S. Wolfarth.
Potencial antipsychotic and extrapyramidal effects of (RS)-3,4-dicarboxyphenylglycine ((RS)-3,4-DCPG), a mixed AMPA antagonist/mGluR8 agonist.
Pol J Pharmacol, 56 (2004), pp. 295-304
[18.]
A.H. Bergvall, J.V. Matuszczyk, L.G. Dahöf, S. Hansen.
Peripheral anosmia attenuates female-enhanced aggression in male mice.
Physiol Behav, 10 (1991), pp. 79-81
[19.]
R.A. Mugford, N.M. Novell.
Pheromones and their effect on aggression in mice.
Nature, 226 (1970), pp. 967-968
[20.]
P.F. Brain, K.H. McAllister, S. Walmsey.
Drug effects on social behaviour.
Neuromethods, pp. 687-739
[21.]
B. Oliver, L.J. Young.
Animal models of aggression.
Neuropsychopharmacology: The fifth generation of progress, pp. 1699-1708
[22.]
J.E. McEllistrem.
Affective and predatory violence: A bimodal classification system of human aggression and violence.
Aggr Viol Behav, 10 (2004), pp. 1-30
[23.]
A. Siegel, S. Bhatt, R. Bhatt, S.S. Zalcman.
The neurobiological bases for development of pharmacological treatment of aggressive disorders.
Curr Neuropharmacol, 5 (2007), pp. 135-147
[24.]
A.M. Linden, M. Bergeron, M. Baez, D.D. Schoepp.
Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice.
Neuropharmacology, 45 (2003), pp. 473-483
[25.]
R.M. Duvoisin, C. Zhang, T.F. Pfankuch, H. O’Connor, J. Gayet-Primo, S. Quraishi, et al.
Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8.
Eur J Neurosci, 22 (2005), pp. 425-436
[26.]
P. Bäckström, P. Hyytiä.
Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.
Eur J Pharmacol, 528 (2005), pp. 110-118
[27.]
I. Marabese, F. Rossi, E. Palazzo, V. De Novellis, K. Starowicz, L. Cristino, et al.
Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception.
J Neurophysiol, 98 (2007), pp. 43-53
Copyright © 2009. SEP y SEPB
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos